PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact


Search


PDF Archive search engine
Last database update: 28 November at 18:09 - Around 89000 files indexed.

Show results per page

Results for «prostate»:


Total: 80 results - 0.07 seconds

JDIT-2016-0906-024 100%

2057-3782 (Online) http://www.openmedscience.com CASE REPORT Solitary Increase of 11C-Choline Uptake in an Enchondroma Patient with Biochemical Recurrence of Prostate Cancer Giampiero Giovacchini1,* and Andrea Ciarmiello2 1 Institute of Radiology and Nuclear Medicine, Stadtspital Triemli, Zurich, Switzerland 2 Nuclear Medicine Department, S.

https://www.pdf-archive.com/2017/05/30/jdit-2016-0906-024/

30/05/2017 www.pdf-archive.com

07d0c77d5987f908461f9f7c33741941 97%

• Apply Level 1 evidence on the use of chemotherapy in men with newly diagnosed metastatic prostate cancer • Apply Level 1 evidence on the use of active surveillance for men with newly diagnosed low or intermediate risk prostate cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced renal cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced bladder cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced testicular cancer WHO SHOULD ATTEND:

https://www.pdf-archive.com/2018/07/15/07d0c77d5987f908461f9f7c33741941/

15/07/2018 www.pdf-archive.com

JDIT-2014-1028-005 95%

www.openmedscience.com Case Report R Abiraterone and Volumetric Modulated Arc Therapy for Second Recurrence of Node-Positive Prostate Cancer - A Case Report Finn Edler von Eyben1,*, Timo Joensuu2, Aki Kangasmaki2, Kalevi Kairemo2, Timo Kiljunen2 1 Center of Tobacco Control Research, Odense, Denmark, 2Docrates Cancer Center, Helsinki, Finland *Author to whom correspondence should be addressed:

https://www.pdf-archive.com/2017/05/30/jdit-2014-1028-005/

30/05/2017 www.pdf-archive.com

programme-jolonc-2013 93%

Docteur Jean-Marc BACHAUD Docteur Françoise PENE (Paris) Docteur Nadia LEVASSEUR 14 h 00 – 14 h 30 Epidémiologie des cancers urologiques (Docteur Matthieu THOULOUZAN - Toulouse) 14 h 30 – 15 h 00 Intérêt du dépistage du cancer de la prostate en 2013 (Professeur Bernard MALAVAUD - Toulouse Docteur Ahmed MANSOURI – Cahors - Toulouse) 15 h 00 – 15 h 30 Biologie moléculaire des cancers urologiques (vessie – prostate) (Docteur Catherine MAZEROLLES - Toulouse) 15 h 30 – 16 h 00 Place des traitements focaux dans la prise en charge des cancers localisés de la prostate (Professeur Pascal RISCHMANN - Toulouse) 16 h 00 – 16 h 15 Pause café Modérateurs :

https://www.pdf-archive.com/2018/06/19/programme-jolonc-2013/

19/06/2018 www.pdf-archive.com

sextoylux 92%

Shop the Best Selling Prostate Massagers and prostate toys at affordable price only on Sextoylux.

https://www.pdf-archive.com/2018/05/09/sextoylux/

09/05/2018 www.pdf-archive.com

sawpalmetto 91%

with sales exceeding $18 billion in 2005.1 Among the most commonly used phytotherapeutics is an extract of the berry of the saw palmetto plant, a dwarf palm tree native to the southeastern U.S.2,3 Saw palmetto extracts are generally used to relieve symptoms associated with benign prostatic hyperplasia (BPH), a non-malignant enlargement of the prostate gland affecting the majority of men over the age of 50.4 Because saw palmetto extracts are sold without prescription, it is difficult to determine the numbers of men who take the extract regularly, but it is estimated that the number of regular users is approximately 2.5 million adults in the U.S.5 The efficacy of saw palmetto (also known as Serenoa repens) is currently the subject of active investigation by several research groups.

https://www.pdf-archive.com/2016/08/25/sawpalmetto/

25/08/2016 www.pdf-archive.com

2017DBS Antibody Flyer 102017 web 91%

NKX3.1 is more sensitive than prostate specific antigen (PSA) for metastatic prostate carcinoma.

https://www.pdf-archive.com/2017/10/30/2017dbs-antibody-flyer-102017-web/

30/10/2017 www.pdf-archive.com

813607 JD October2017 (3) 90%

 To deliver external beam radiotherapy for prostate cancer and high dose rate prostate brachytherapy (training will be provided as required).

https://www.pdf-archive.com/2018/01/01/813607-jd-october2017-3/

01/01/2018 www.pdf-archive.com

Urology Congress Programme 89%

David Quinn Mark Soloway Monish Aron William Catalona Mihir Desai Joel Sheinfield Inderbir Gill “LIVE” Robotic Surgeries Robotic Kidney q *7$ UISPNCFDUPNZ q 0Ю $MBNQ 1BSUJBM /FQISFDUPNZ Robotic Bladder Robotic Prostate q 3BEJDBM OFSWF TQBSJOH QSPTUBUFDUPNZ q 4BMWBHF SBEJDBM QSPTUBUFDUPNZ q 4BMWBHF 31-/% 1-/% GPS OPEF POMZ QPTJUJWF SFDVSSFODF q 3BEJDBM DZTUFDUPNZ XJUI IJHI -/% q *OUSB DPSQPSFBM TUBQMFE 7*1 QPVDI q *OUSB DPSQPSFBM TVUVSFE OFPCMBEEFS Info:

https://www.pdf-archive.com/2016/05/02/urology-congress-programme/

02/05/2016 www.pdf-archive.com

KConfab May2016-web 87%

We have also continued to expand our work in prostate and pancreatic cancer as these cancers can also occur in our kConFab families.

https://www.pdf-archive.com/2016/06/02/kconfab-may2016-web/

02/06/2016 www.pdf-archive.com

March Programme 2017 87%

Thursday 9th March PROSTATE CANCER LANARKSHIRE 1.00 - 2.30 Neil Armstrong chats about the support offered locally and the Maggie Centre Thursday 16th March PETER &

https://www.pdf-archive.com/2017/03/07/march-programme-2017/

07/03/2017 www.pdf-archive.com

2017064552 170802104049 Results M522 Well Man UltraVit 84%

CP149719,CP148602 WELL MAN ULTRAVIT Test Result IRON T.I.B.C TRANSFERRIN SATURATION FERRITIN 27.47 66.87 41.08 102 Units Range BIOCHEMISTRY Iron Status umol/L umol/L % ug/L 10.60 41.00 20.00 30.00 mmol/L mmol/L mmol/L mmol/L nmol/L 0.00 0.00 0.90 0.00 0.00 33.54 % 20.00 - 100.00 THYROID STIMULATING HORMONE FREE THYROXINE 3.92 18.2 mIU/L pmol/L 0.27 - 4.20 12.00 - 22.00 PROSTATE SPECIFIC AG(TOTAL) PROSTATE SPECIFIC AG(FREE) FREE:TOTAL RATIO 0.389 0.168 0.43 ug/L ug/L 0.00 - 1.40 0.00 - 0.90 0.19 - 1.00 TESTOSTERONE 12 nmol/L 7.60 - 31.40 VITAMIN B12 FOLATE (SERUM) 25 OH VITAMIN D 158 3.88 54.5 pmol/L ug/L nmol/L 140.00 - 724.00 2.91 - 50.00 50.00 - 200.00 Cholesterol Status TRIGLYCERIDES CHOLESTEROL HDL CHOLESTEROL LDL CHOLESTEROL Non-HDL Cholesterol Heart Disease Risk HDL % OF TOTAL 1.43 4.8 *1.61 2.54 3.19 - – 28.30 77.00 55.00 400.00 2.30 4.99 1.50 3.00 3.99 ENDOCRINOLOGY Thyroid Function Prostate Screen Hormone HAEMATOLOGY Vitamins Interpretation of results:

https://www.pdf-archive.com/2017/08/22/2017064552-170802104049-results-m522-well-man-ultravit/

22/08/2017 www.pdf-archive.com

JDIT-2017-0120-025 84%

prostate cancer 1.

https://www.pdf-archive.com/2017/05/30/jdit-2017-0120-025/

30/05/2017 www.pdf-archive.com

JDIT-2014-1110-007 83%

For example, genome-wide association meta-analyses has confirmed the involvement of multiple variants in prostate cancer, breast cancer, diabetes and schizophrenia [6].

https://www.pdf-archive.com/2017/05/30/jdit-2014-1110-007/

30/05/2017 www.pdf-archive.com

Editorial Review 2017 78%

The fourth article, ‘Radioimmunotherapy of Metastatic Prostate Cancer with 177Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody,’ by Vallabhajosula et al.

https://www.pdf-archive.com/2017/05/29/editorial-review-2017/

29/05/2017 www.pdf-archive.com

ER1107 76%

Rodica Anghel 15:00 - 16:30 Interesting cases from audience 16.30 Tumor board melanoma and sarcoma RCC, Bladder, Prostate 12:15-13:00 Bladder cancer radiotherapy:

https://www.pdf-archive.com/2018/09/11/er1107/

11/09/2018 www.pdf-archive.com

JDIT-2015-0202-011 75%

Since the conception of JDIT in the latter part of 2014, we have had the pleasure to receive a variety of research articles, reviews, commentaries, perspectives and case reports ranging from topics on the use of PET imaging, automated radiosynthesis, 18F-FES-PET/CT imaging of breast cancer, prostate cancer therapy and imaging, PET/CT imaging of neuroendocrine tumours using 68Ga-somatostatin analogues, targeted radionuclide therapy, transcranial sonography applications for movement disorders, the application of 18F-fluoride as a marker of unstable atheroma and the use of radionuclides in diagnostic imaging and therapy.

https://www.pdf-archive.com/2017/05/30/jdit-2015-0202-011/

30/05/2017 www.pdf-archive.com

SESSIONS RSNA2015 75%

PROSTATE Wednesday December 2 Scientific Posters ShearWave™ Elastography Presentations LL-NRE4480, 12:45 - 1:15pm, Learning Center, Hall D, Station#2 Patient-specific Prostate Deformation Modelling via ShearWave tography for TRUS-guided Interventions TM Elas- BREAST Yi Wang Hong Kong, Hong Kong (Presenter), Dong Ni, BEng, MPH Hongkong, China, Jing Qin Shenzhen, China, Ming Xu Guangzhou, China, Xiaoyan Xie Guangzhou, China, Pheng Ann Heng, PhD Shatin, Hong Kong PURPOSE:

https://www.pdf-archive.com/2015/11/30/sessions-rsna2015/

30/11/2015 www.pdf-archive.com

SAVVY MAP Policy Dec 2016 F4 (2) (6) 74%

Price VI-F0301 NEW BAM™ RECHARGEABLE BULLET - TEASE ME TURQUOISE BULLET VIBE 731882511550 12 48 $ 44.99 $ 40.00 $ 20.00 $ - VI-F0309 NEW BAM™ RECHARGEABLE BULLET - FOXY PINK BULLET VIBE 731882511536 12 48 $ 44.99 $ 40.00 $ 20.00 $ - VI-F0303 NEW BAM™ RECHARGEABLE BULLET - INTO YOU INDIGO BULLET VIBE 731882511543 12 48 $ 44.99 $ 40.00 $ 20.00 $ - VI-M0601 NEW GEEplus™ RECHARGEABLE VIBE - TEASE ME TURQUOISE BULLET VIBE 731882511703 12 48 $ 49.99 $ 43.99 $ 22.00 $ - VI-M0609 NEW GEEplus™ RECHARGEABLE VIBE - FOXY PINK BULLET VIBE 731882511727 12 48 $ 49.99 $ 43.99 $ 22.00 $ - VI-M0603 NEW GEEplus™ RECHARGEABLE VIBE - INTO YOU INDIGO BULLET VIBE 731882511710 12 48 $ 49.99 $ 43.99 $ 22.00 $ - VI-M0701 NEW LUVplus™ RECHARGEABLE VIBE - TEASE ME TURQUOISE BULLET VIBE 731882511673 12 48 $ 48.99 $ 42.99 $ 21.50 $ - VI-M0709 NEW LUVplus™ RECHARGEABLE VIBE - FOXY PINK BULLET VIBE 731882511697 12 48 $ 48.99 $ 42.99 $ 21.50 $ - VI-M0703 NEW LUVplus™ RECHARGEABLE VIBE - INTO YOU INDIGO BULLET VIBE 731882511680 12 48 $ 48.99 $ 42.99 $ 21.50 $ - VI-R0406 NEW OVERDRIVE™ RECHARGEABLE VIBRATING RING - MIDNIGHT MADNESS BULLET VIBE 731882511611 12 48 $ 34.99 $ 29.99 $ 15.00 $ - VI-R0408 NEW OVERDRIVE™ RECHARGEABLE VIBRATING RING - JUST BLACK BULLET VIBE 731882511628 12 48 $ 34.99 $ 29.99 $ 15.00 $ - VI-S0203 NEW SHAKER™ ANAL CHAIN - INTO YOU INDIGO ANAL 731882511635 12 48 $ 14.99 $ 12.99 $ 6.50 $ - VI-S0208 NEW SHAKER™ ANAL CHAIN - JUST BLACK ANAL 731882511642 12 48 $ 14.99 $ 12.99 $ 6.50 $ - VI-BAT12 NEW BATTERIES™ LR41 - 12 PACK 1.5V ACCESSORY 731882511512 12 96 $ 5.99 $ 4.99 $ 2.50 $ - VI-SC001 NEW SECURITY CORD™ ACCESSORY 731882511567 24 144 $ 3.50 $ - VI-P0606 NEW COWBOY™ RECHARGEABLE PROSTATE VIBE - MIDNIGHT MADNESS PROSTATE VIBE 731882511451 12 24 $ 79.99 $ 68.00 $ 34.00 $ - VI-P0608 NEW COWBOY™ RECHARGEABLE PROSTATE VIBE -JUST BLACK PROSTATE VIBE 731882511468 12 24 $ 79.99 $ 68.00 $ 34.00 $ - VI-P0608-TESTER NEW COWBOY™ RECHARGEABLE PROSTATE VIBE -JUST BLACK - TESTER TESTER 731882511468 12 12 FREE WITH MIN PURCHASE $ $ - VI-P0708 NEW RIO GRANDE™ANAL VIBE - JUST BLACK - MEN'S ANAL VIBE 731882511529 12 24 $ 59.99 $ 52.00 $ 26.00 $ - VI-P0708-TESTER NEW RIO GRANDE™ANAL VIBE - JUST BLACK - MEN'S - TESTER TESTER 731882511529 1 12 FREE WITH MIN PURCHASE $ $ - VI-P0808 NEW EARTH QUAKER™ANAL VIBE - JUST BLACK - MEN'S ANAL VIBE 731882511598 12 24 $ 69.99 $ 60.00 $ 30.00 $ - VI-P0903 NEW COWGIRL™ DUAL VIBE - INTO YOU INDIGO DUAL VIBE 731882511581 12 24 $ 74.99 $ 64.99 $ 32.50 $ - VI-P0909 NEW COWGIRL™ DUAL VIBE - FOXY PINK DUAL VIBE 731882511574 12 24 $ 74.99 $ 64.99 $ 32.50 $ - GEE™ MINI VIBE - TEASE ME TURQUOISE MINI VIBE 854306004183 12 48 $ 27.99 $ 23.99 $ 12.00 $ - VI-M0201 Page 1 NA NA - - SAVVY price list_7.1.16.xlsx VI-M0203 GEE™ MINI VIBE - INTO YOU INDIGO MINI VIBE 854306004213 12 48 $ 27.99 $ 23.99 $ 12.00 $ - VI-M0204 GEE™ MINI VIBE - MAKE ME BLUSH PINK MINI VIBE 854306004190 12 48 $ 27.99 $ 23.99 $ 12.00 $ - VI-M0402 LUV™ MINI VIBE - HOT IN BED PINK MINI VIBE 854306004268 12 48 $ 26.99 $ 22.99 $ 11.50 $ - VI-M0403 LUV™ MINI VIBE - INTO YOU INDIGO MINI VIBE 854306004275 12 48 $ 26.99 $ 22.99 $ 11.50 $ - VI-M0404 LUV™ MINI VIBE - MAKE ME BLUSH PINK MINI VIBE 854306004251 12 48 $ 26.99 $ 22.99 $ 11.50 $ - VI-M0503 BUB™ MINI VIBE - INTO YOU INDIGO MINI VIBE 854306004855 12 48 $ 29.99 $ 24.99 $ 12.50 $ - VI-M0509 BUB™ MINI VIBE - FOXY PINK MINI VIBE 854306004831 12 48 $ 29.99 $ 24.99 $ 12.50 $ - VI-M0510 BUB™ MINI VIBE - VIXEN VIOLET MINI VIBE 854306004848 12 48 $ 29.99 $ 24.99 $ 12.50 $ - VI-M0303 EVA™ MINI VIBE - INTO YOU INDIGO MINI VIBE 854306004244 12 48 $ 29.99 $ 24.99 $ 12.50 $ - VI-M0304 EVA™ MINI VIBE - MAKE ME BLUSH PINK MINI VIBE 854306004237 12 48 $ 29.99 $ 24.99 $ 12.50 $ - VI-M0305 EVA™ MINI VIBE - ORGASMIC ORCHID MINI VIBE 854306004220 12 48 $ 29.99 $ 24.99 $ 12.50 $ - VI-F0201 AYU™ MINI FINGER VIBE PAIR - BLACK &

https://www.pdf-archive.com/2017/02/22/savvy-map-policy-dec-2016-f4-2-6/

22/02/2017 www.pdf-archive.com

5129 w12 ms 21 71%

do not accept directly proportional [1] (b) (i) B [1] (ii) potential to kinetic 4 Syllabus 5129 (a) pencil does not mix with the dyes (or converse) pencil insoluble in water (c) 3 Mark Scheme GCE O LEVEL – October/November 2012 [1] (a) (i) obese student D correct weight student B [2] (b) (i) cheese beef [2] (ii) take more exercise reduce total food intake / eat less [1] (c) (i) fibre is the part of the food that cannot be digested (ii) muscles of alimentary canal can grip on it peristalsis more efficient / rapid prevents constipation [1] any 2 © Cambridge International Examinations 2012 [2] Page 3 5 Mark Scheme GCE O LEVEL – October/November 2012 Syllabus 5129 (a) (i) 14 [1] (ii) 6 6 [1] (b) 2, 4 [1] (c) covalent (must have for first mark) electrons shared to make full outer shell / inert gas structure [3] (a) A and C (both) [1] (b) (i) 0.3 [1] (ii) V = IR or R = V / I or 1.5 / 0.2 = 7.5 Ω (unit independent) 7 Paper 21 [3] breaks down alcohol kidney destroys hormones excretes carbon dioxide liver excretes urea lung forms urea 8 [5] (a) (i) hydrogen / H+ [1] (ii) hydroxide / OH– [1] (b) (i) 7 [1] (ii) green [1] (iii) 22 [1] (iv) H+ + OH– H2O © Cambridge International Examinations 2012 [1] Page 4 9 Mark Scheme GCE O LEVEL – October/November 2012 Syllabus 5129 (a) (i) approximately correct direction [1] (ii) 48 [1] (b) (i) ray bends towards normal (ignore lines below block) 10 (a) (i) prostate gland testis urethra (ii) prostate gland testis urethra Paper 21 [1] C E D [3] secretes fluid / semen / seminal fluid produces sperm produces / secretes hormone / testosterone / androgen transports sperm / semen / seminal fluid (do not accept :

https://www.pdf-archive.com/2016/06/10/5129-w12-ms-21/

10/06/2016 www.pdf-archive.com

May June 2017 (1) 66%

Knit 12:30-2 pm Canton Yoga 6-7 pm Prostate Group 6-7:30 pm Breast Cancer Grp.

https://www.pdf-archive.com/2017/04/24/may-june-2017-1/

24/04/2017 www.pdf-archive.com

AncientCancer 63%

Lung, breast, colorectal and prostate cancers will account for more than half of all new cases.

https://www.pdf-archive.com/2014/04/05/ancientcancer/

05/04/2014 www.pdf-archive.com

Myriad Negative NoVus FmHx 62%

• Management recommendations are provided for personal/family history of colorectal adenomas, breast, colorectal, melanoma, pancreatic, and prostate cancers.

https://www.pdf-archive.com/2017/05/23/myriad-negative-novus-fmhx/

23/05/2017 www.pdf-archive.com

rfl 62%

In my family alone there has been lung, brain, prostate, bladder, liver, and blood (Leukemia) cancer.

https://www.pdf-archive.com/2013/01/29/rfl/

29/01/2013 www.pdf-archive.com